Named on one round in the feed.
Since 2026-10-14
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
seragy holding GmbH A provider of a biomarker strategy platform focused on neurodegenerative diseases and other proteopathies | Funding round Developing, 12 sources | $13.4M | 2026-10-14 | [ PART ] |